Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 4 Pancreatic Neoplasms 3 Lung Neoplasms 2 Liver Neoplasms 2 Agnosia 2 Uterine Cervical Neoplasms 1 Thoracic Neuritis 1 Stomach Neoplasms 1 Reperfusion Injury 1 Prostatic Neoplasms 1 Neoplasms 1 Leiomyoma 1 Inflammation 1 Endometrial Neoplasms 1 End Stage Liver Disease 1 Colonic Neoplasms 1 Breast Neoplasms 1 Breast Cancer Female 1 Bites and Stings 1 Biliary Tract Neoplasms 1 Adenomyosis 1 Acute Pain 1

Interventions

pembrolizumab 3 enzalutamide 2 blinatumomab 2 abiraterone 2 Stents 2 Neoadjuvant Therapy 2 Immune Checkpoint Inhibitors 2 Cytochrome P-450 Enzyme System 2 AMG 757 2 soybean oil, phospholipid emulsion 1 durvalumab 1 dostarlimab 1 cemiplimab 1 camrelizumab 1 atezolizumab 1 Surgical Procedures, Operative 1 Surgical Instruments 1 Radiotherapy, Conformal 1 Radiotherapy 1 Passive Cutaneous Anaphylaxis 1 Palliative Care 1 Nephrotomy 1 Nephrostomy, Percutaneous 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Morphine 1 Lidocaine 1 Levobupivacaine 1 Immunotherapy 1 Hydroxyurea 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Bites and Stings × Analgesia, Patient-Controlled × Clear all

NCT03165383 2017-05-24

TAP

Rajiv Gandhi Cancer Institute & Research Center, India

Phase NA Completed

Bites and Stings

Data powered by HemOnc (CC BY 4.0) Colophon ⚡